Grupo Rehabilitacion en Salud
5
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 5/100
0.0%
0 terminated/withdrawn out of 5 trials
100.0%
+13.5% vs industry average
40%
2 trials in Phase 3/4
75%
3 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
TeleEducation for Implementing a Clinical Practice Guideline For Amputees
Role: lead
Effectiveness of a Cardiac Rehabilitation Program in Patients With Heart Failure
Role: lead
Natriuretic Brain Pro-peptid Changes in Patients With Chronic Heart Failure Within a Cardiac Rehabilitation Program
Role: lead
Treatment of Myofascial Pain Syndrome With Lidocaine Injection and Physical Therapy.
Role: lead
Improvement in Pain,Function and HRQoL ( Health Related Quality of Life) in Subacute Low Back Pain: A Controlled Clinical Trial of Exercise vs NSAIDs (Nonsteroidal Antiinflammatory)
Role: lead
All 5 trials loaded